126 related articles for article (PubMed ID: 8330997)
1. Phase I/II trial of accelerated fractionation in brain metastases RTOG 85-28.
Sause WT; Scott C; Krisch R; Rotman M; Sneed PK; Janjan N; Davis L; Curran W; Choi KN; Selim H
Int J Radiat Oncol Biol Phys; 1993 Jul; 26(4):653-7. PubMed ID: 8330997
[TBL] [Abstract][Full Text] [Related]
2. A randomized phase III study of accelerated hyperfractionation versus standard in patients with unresected brain metastases: a report of the Radiation Therapy Oncology Group (RTOG) 9104.
Murray KJ; Scott C; Greenberg HM; Emami B; Seider M; Vora NL; Olson C; Whitton A; Movsas B; Curran W
Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):571-4. PubMed ID: 9336134
[TBL] [Abstract][Full Text] [Related]
3. Improved survival duration in patients with unresected solitary brain metastasis using accelerated hyperfractionated radiation therapy at total doses of 54.4 gray and greater. Results of Radiation Therapy Oncology Group 85-28.
Epstein BE; Scott CB; Sause WT; Rotman M; Sneed PK; Janjan NA; Davis LW; Selim H; Mohiuddin M; Wasserman TH
Cancer; 1993 Feb; 71(4):1362-7. PubMed ID: 8435812
[TBL] [Abstract][Full Text] [Related]
4. A phase I/II study to evaluate accelerated fractionation via concomitant boost for squamous, adeno, and large cell carcinoma of the lung: report of Radiation Therapy Oncology Group 84-07.
Byhardt RW; Pajak TF; Emami B; Herskovic A; Doggett RS; Olsen LA
Int J Radiat Oncol Biol Phys; 1993 Jun; 26(3):459-68. PubMed ID: 8390420
[TBL] [Abstract][Full Text] [Related]
5. Importance of the mini-mental status examination in the treatment of patients with brain metastases: a report from the Radiation Therapy Oncology Group protocol 91-04.
Murray KJ; Scott C; Zachariah B; Michalski JM; Demas W; Vora NL; Whitton A; Movsas B
Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):59-64. PubMed ID: 10924972
[TBL] [Abstract][Full Text] [Related]
6. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW
Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913
[TBL] [Abstract][Full Text] [Related]
7. Neurocognitive outcome in brain metastases patients treated with accelerated-fractionation vs. accelerated-hyperfractionated radiotherapy: an analysis from Radiation Therapy Oncology Group Study 91-04.
Regine WF; Scott C; Murray K; Curran W
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):711-7. PubMed ID: 11597813
[TBL] [Abstract][Full Text] [Related]
8. A phase I study of short-course accelerated whole brain radiation therapy for multiple brain metastases.
Caravatta L; Deodato F; Ferro M; Macchia G; Massaccesi M; Cilla S; Padula GD; Mignogna S; Tambaro R; Carrozza F; Flocco M; Cantore G; Scapati A; Buwenge M; Sticca G; Valentini V; Cellini N; Morganti AG
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):e463-8. PubMed ID: 22909415
[TBL] [Abstract][Full Text] [Related]
9. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003.
Fu KK; Pajak TF; Trotti A; Jones CU; Spencer SA; Phillips TL; Garden AS; Ridge JA; Cooper JS; Ang KK
Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):7-16. PubMed ID: 10924966
[TBL] [Abstract][Full Text] [Related]
10. Randomized phase I/II trial of two variants of accelerated fractionated radiotherapy regimens for advanced head and neck cancer: results of RTOG 88-09.
Fu KK; Clery M; Ang KK; Byhardt RW; Maor MH; Beitler JJ
Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):589-97. PubMed ID: 7790243
[TBL] [Abstract][Full Text] [Related]
11. Accelerated hyperfractionated hepatic irradiation in the management of patients with liver metastases: results of the RTOG dose escalating protocol.
Russell AH; Clyde C; Wasserman TH; Turner SS; Rotman M
Int J Radiat Oncol Biol Phys; 1993 Sep; 27(1):117-23. PubMed ID: 8365932
[TBL] [Abstract][Full Text] [Related]
12. Standard-dose versus higher-dose prophylactic cranial irradiation (PCI) in patients with limited-stage small-cell lung cancer in complete remission after chemotherapy and thoracic radiotherapy (PCI 99-01, EORTC 22003-08004, RTOG 0212, and IFCT 99-01): a randomised clinical trial.
Le Péchoux C; Dunant A; Senan S; Wolfson A; Quoix E; Faivre-Finn C; Ciuleanu T; Arriagada R; Jones R; Wanders R; Lerouge D; Laplanche A;
Lancet Oncol; 2009 May; 10(5):467-74. PubMed ID: 19386548
[TBL] [Abstract][Full Text] [Related]
13. Analysis of outcome in patients reirradiated for brain metastases.
Wong WW; Schild SE; Sawyer TE; Shaw EG
Int J Radiat Oncol Biol Phys; 1996 Feb; 34(3):585-90. PubMed ID: 8621282
[TBL] [Abstract][Full Text] [Related]
14. A phase I/II study to evaluate the effect of fractionated hemibody irradiation in the treatment of osseous metastases--RTOG 88-22.
Scarantino CW; Caplan R; Rotman M; Coughlin C; Demas W; Delrowe J
Int J Radiat Oncol Biol Phys; 1996 Aug; 36(1):37-48. PubMed ID: 8823257
[TBL] [Abstract][Full Text] [Related]
15. Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer.
Sause WT; Scott C; Taylor S; Johnson D; Livingston R; Komaki R; Emami B; Curran WJ; Byhardt RW; Turrisi AT
J Natl Cancer Inst; 1995 Feb; 87(3):198-205. PubMed ID: 7707407
[TBL] [Abstract][Full Text] [Related]
16. Phase I trial of simultaneous in-field boost with helical tomotherapy for patients with one to three brain metastases.
Rodrigues G; Yartsev S; Yaremko B; Perera F; Dar AR; Hammond A; Lock M; Yu E; Ash R; Caudrelier JM; Khuntia D; Bailey L; Bauman G
Int J Radiat Oncol Biol Phys; 2011 Jul; 80(4):1128-33. PubMed ID: 20675078
[TBL] [Abstract][Full Text] [Related]
17. Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost in Patients With Brain Oligometastases: A Phase 1 Study (ISIDE-BM-1).
Ferro M; Chiesa S; Macchia G; Cilla S; Bertini F; Frezza G; Farioli A; Cammelli S; Balducci M; Ianiro A; Angelini AL; Compagnone G; Valentini V; Deodato F; Morganti AG
Int J Radiat Oncol Biol Phys; 2017 Jan; 97(1):82-90. PubMed ID: 27843034
[TBL] [Abstract][Full Text] [Related]
18. Three-dimensional conformal radiation therapy for non-small-cell lung cancer: a phase I/II dose escalation clinical trial.
Wu KL; Jiang GL; Liao Y; Qian H; Wang LJ; Fu XL; Zhao S
Int J Radiat Oncol Biol Phys; 2003 Dec; 57(5):1336-44. PubMed ID: 14630271
[TBL] [Abstract][Full Text] [Related]
19. Results of a phase II study of Short-course Accelerated Radiation Therapy (SHARON) for multiple brain metastases.
Caravatta L; Deodato F; Ferro M; Macchia G; Massaccesi M; Cilla S; Tambaro R; Mignogna S; Padula GD; Musacchio M; Flocco M; Cantore G; Scapati A; Bogale S; Balducci M; Valentini V; Cellini N; Morganti AG
Am J Clin Oncol; 2015 Aug; 38(4):395-400. PubMed ID: 26214084
[TBL] [Abstract][Full Text] [Related]
20. Strong correlation between imaging response and survival among patients with primary central nervous system lymphoma: a secondary analysis of RTOG studies 83-15 and 88-06.
Corn BW; Dolinskas C; Scott C; Donahue B; Schultz C; Nelson DF; Fisher B
Int J Radiat Oncol Biol Phys; 2000 May; 47(2):299-303. PubMed ID: 10802352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
